Industry6 min read
Semaglutide 7.2 mg Hits US: 20.7% Weight Loss
The new high-dose 7.2 mg pen is shipping after FDA priority approval. STEP UP hit 20.7% mean loss — what it means for research peptide buyers.
Peptide Industry News
Brand launches, primer pieces, broader coverage.
Daily Peptide News
New articles delivered to your inbox every morning. Free.
Industry News
Industry6 min read
Semaglutide Cuts Heavy Drinking 41%: Lancet AUD Trial
Lancet phase 2b: 2.4 mg semaglutide cut heavy drinking days 41% in 26 weeks. What the data means for buyers, dose, and where to source.
Industry11 min read
$30 vs $300 Semaglutide: Where the Money Goes
Same Chinese factories, 10x price gap. We break down every dollar of compounded GLP-1 markup — what's real safety value vs telehealth marketing.
Industry8 min read
Ozempic Pill Launches in US: New Dose Strengths
Novo Nordisk's reformulated Ozempic tablets (1.5, 4, 9 mg) hit US pharmacies May 4. What changed, the new prices, and where compounded still wins.
Industry7 min read
Medicaid GLP-1 Coverage Starts May 1: BALANCE Model Live
CMS launched BALANCE Medicaid GLP-1 coverage May 1 — but Part D was just delayed. What it means for branded vs compounded buyers right now.
Industry5 min read
The Peptide Media Panic: What They Got Wrong
The New Yorker, NBC, and STAT ran peptide scare stories in April 2026. Here is what they nailed, what they missed, and how to actually stay safe.
Industry8 min read
GLP-1 Not Needed for Weight Loss? GIP/Glucagon
DiMarchi, who pioneered GLP-1 obesity drugs, now says GIP/glucagon alone may match GLP-1 — without nausea. What it means for retatrutide buyers.
Industry4 min read
GLP-1 Genetic Resistance: What to Do If You're a Non-Responder
10% of people carry gene variants that reduce GLP-1 drug response. How to tell if you're one, what the research says, and which alternatives actually work.
Industry10 min read
GHRH vs GHRP: Different Receptors Guide
They both boost GH but through completely different pathways. Mechanisms, stacking logic, and which to use when.
Industry5 min read
Stanford BRP Peptide: Weight Loss Without Nausea
Stanford's BRP peptide cuts appetite 50% via the hypothalamus — no nausea or muscle loss. What it means for peptide buyers right now.
Industry6 min read
40% of Peptides Fail Purity Tests: How to Verify
Independent labs found 40% of peptide vendors fail purity claims. Learn to read COAs, spot red flags, and verify before you inject.
Industry4 min read
Utah Doctor Indicted for Fake Peptides: Lessons
A Utah physician sold Chinese-made peptides with fake labels to 200+ patients. How to verify your vendor's COAs and avoid counterfeit peptides.
Industry5 min read
GLP-1 Weight Regain: What Happens When You Stop
You regain 60% of lost weight within a year of stopping semaglutide. Here's exactly why, what the new meta-analyses show, and 4 strategies to keep it off.
Industry13 min read
Peptides vs Supplements: Why They're Not the Same
Supplement makers want FDA to allow peptides as ingredients. The molecular mechanisms say that's comparing a scalpel to a multivitamin.
Industry13 min read
Peptides and TRT: 8 Synergies That Amplify Results
GH peptides hit harder on TRT — but only certain combos matter. 8 synergistic pairings with mechanisms, doses, and protocols.